Maccari S, Le Moal M, Angelucci L, Mormède P
Laboratoire de Physchobiologie des Comportements Adaptatifs, I.N.S.E.R.M. U259-I.N.R.A., Bordeaux, France.
Brain Res. 1990 Nov 12;533(1):60-5. doi: 10.1016/0006-8993(90)91795-i.
Two types of receptor for adrenocortical hormones (type I or mineralocorticoid and type II or glucocorticoid) in the hippocampus and hypothalamus mediate the effects of corticosteroids on various brain functions including the negative feedback control of hypothalamo-pituitary-adrenal (HPA) axis activity. These brain regions are also densely innervated by noradrenergic terminals which may play a role in the regulation of HPA axis activity and the feedback action of corticosteroids. However, direct evidence for a noradrenergic control of corticosterone receptors is lacking. The present experiments tested the effects of 6-hydroxydopamine lesion of noradrenergic ascending pathways at the level of the pedunculus cerebellaris superior (PCS) on the status of type I and type II corticosteroid receptors. Binding of [3H]corticosterone was evaluated in cytosolic fractions of 24-h adrenalectomized animals 3 weeks after surgery. The PCS lesion produced an up-regulation of type I corticosteroid receptors in the hippocampus and of the type II receptor in the hypothalamus. The number of these receptors (Bmax) increased without any change in their affinity for corticosterone (Kd). Furthermore, in a functional study, we tested the effects of the lesion on the neuroendocrine responses to stress. Plasma corticosterone levels were lower in lesioned rats both under basal conditions and in response to the stress of gentle handling or exposure to footshock, indicating reduced activity of the HPA axis. These results are in line with recent studies indicating a facilitatory function of noradrenergic pathways on the HPA axis and suggest that this action could be mediated via a modulation of corticosteroid receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
海马体和下丘脑中有两种肾上腺皮质激素受体(I型或盐皮质激素受体和II型或糖皮质激素受体),介导皮质类固醇对各种脑功能的影响,包括下丘脑-垂体-肾上腺(HPA)轴活动的负反馈控制。这些脑区也被去甲肾上腺素能终末密集支配,其可能在HPA轴活动调节和皮质类固醇的反馈作用中发挥作用。然而,缺乏去甲肾上腺素能对皮质酮受体进行控制的直接证据。本实验测试了在小脑上脚(PCS)水平对去甲肾上腺素能上行通路进行6-羟基多巴胺损伤,对I型和II型皮质类固醇受体状态的影响。在术后3周对24小时肾上腺切除动物的细胞溶质部分评估[3H]皮质酮的结合情况。PCS损伤导致海马体中I型皮质类固醇受体和下丘脑II型受体上调。这些受体的数量(Bmax)增加,而它们对皮质酮的亲和力(Kd)没有任何变化。此外,在一项功能研究中,我们测试了损伤对应激神经内分泌反应的影响。无论是在基础条件下还是在轻柔处理或足部电击应激反应中,损伤大鼠的血浆皮质酮水平都较低,表明HPA轴活性降低。这些结果与最近表明去甲肾上腺素能通路对HPA轴具有促进作用的研究一致,并表明这种作用可能通过调节皮质类固醇受体来介导。(摘要截短至250字)